ClinVar Miner

Submissions for variant NM_000166.6(GJB1):c.119C>T (p.Ala40Val) (rs1602348786)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001040086 SCV001203641 pathogenic Charcot-Marie-Tooth Neuropathy X 2019-04-01 criteria provided, single submitter clinical testing This sequence change replaces alanine with valine at codon 40 of the GJB1 protein (p.Ala40Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals affected with Charcot-Marie-Tooth disease (PMID: 8800924, 28768847). This variant has been reported to affect GJB1 protein function (PMID: 12460545). This variant disrupts the p.Ala40 amino acid residue in GJB1. Other variant(s) that disrupt this residue have been observed in individuals with GJB1-related conditions (PMID: 12536289, 28768847), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Inherited Neuropathy Consortium RCV000789265 SCV000928618 uncertain significance Charcot-Marie-Tooth disease no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.